investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Optimization of adoptive immunotherapy with autologous CD20-specific T cells
Brian Till
0 Collaborator(s)
Funding source
National Institutes of Health (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
No posts
Related projects
Harold M Swartz
Direct and Repeated Clinical Measurement of pO2 for Enhancing Cancer Therapy
Non-Hodgkin lymphoma
Radiation Oncology
Ronald Levy
Genetic Basis of Signaling Heterogeneity in Human Follicular Lymphoma
Non-Hodgkin lymphoma
Louis Staudt
Oncogenic Mechanisms and Molecular Targets in Lymphoma
Non-Hodgkin lymphoma
Pathology
Hematology and hematologic malignancies
Micah A Luftig
Host Pathways Regulating Epstein-Barr Virus-Mediated B Cell Growth Transformation
Non-Hodgkin lymphoma
Pathology
Hematology and hematologic malignancies
Eric T. Kool
DNA-carbon Assemblies for Multispectral Imaging
Non-Hodgkin lymphoma
Elliott D Kieff
Epstein-Barr Virus Nuclear Protein in B Cell Growth Transformation
Non-Hodgkin lymphoma
John A Bartlett
Developing Research Capacity in Africa for Studies on HIV-Associated Malignancies
Non-Hodgkin lymphoma
Kenneth Lynn Wright
Natural Killer Cell Regulation by PRDM1 and IRF4/8
Non-Hodgkin lymphoma
Dirk P Dittmer
Regulation of the KSHV Latent Promoter
Non-Hodgkin lymphoma